BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6213052)

  • 1. The cellular target of cyclosporin A action in humans.
    Van Buren CT; Kerman R; Agostino G; Payne W; Flechner S; Kahan BD
    Surgery; 1982 Aug; 92(2):167-74. PubMed ID: 6213052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A T-helper/suppressor ratio in renal allograft recipients after various long-term immunosuppressive regimens.
    Hökl J; Filkuka J; Neumannová M; Sobotová D
    Czech Med; 1989; 12(4):189-92. PubMed ID: 2534374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
    Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M
    J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.
    Fidler JM; DeJoy SQ; Smith FR; Gibbons JJ
    J Immunol; 1986 Apr; 136(8):2747-54. PubMed ID: 2937837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts.
    Sweny P; Tidman N
    Clin Exp Immunol; 1982 Feb; 47(2):445-8. PubMed ID: 6210475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphoid irradiation in kidney and liver transplantation in the baboon: prolonged graft survival and alterations in T cell subsets with low cumulative dose regimens.
    Myburgh JA; Smit JA; Stark JH; Browde S
    J Immunol; 1984 Feb; 132(2):1019-25. PubMed ID: 6228586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity.
    Uhteg LC; Salomon DR; Rocher LL; Kupiec-Weglinski JW; Araujo JL; Rubin MF; Tilney NL; Carpenter CB
    J Immunol; 1985 Sep; 135(3):1800-5. PubMed ID: 3160780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell subsets in a cyclosporin-A treated recipient of cadaveric kidney allograft as defined by theophylline sensitivity and monoclonal antibodies.
    Shohat B; Shapira Z; Servadio C
    Dev Biol Stand; 1984; 57():361-6. PubMed ID: 6396131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
    Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
    Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
    Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
    N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
    Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
    J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human renal allograft and peripheral blood T lymphocyte subpopulations during the onset and treatment of rejection.
    Taube D; Welsh K; Hobby P; Williams DG
    Clin Nephrol; 1984 Sep; 22(3):127-32. PubMed ID: 6237816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.
    Braida M; Knop J
    Immunology; 1986 Dec; 59(4):503-7. PubMed ID: 2948905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production.
    Rümke HC; Terpstra FG; Roos MT; Vossen JM; Dooren LJ; Schellekens PT; Zeijlemaker WP
    Clin Exp Immunol; 1984 Aug; 57(2):467-78. PubMed ID: 6235992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Rejection or infection' predictive value of T-cell subject ratio, before and after heart transplantation.
    O'Toole CM; Maher P; Spiegelhalter DJ; Walker JR; Stovin P; Wallwork J; English TA
    J Heart Transplant; 1985; 4(5):518-24. PubMed ID: 3039098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered immunoregulatory function in long-term renal allograft recipients.
    Guttmann RD; Poulsen RS
    Proc Eur Dial Transplant Assoc; 1981; 18():357-61. PubMed ID: 6460243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
    Van Es A; Tanke HJ; Baldwin WM; Oljans PJ; Ploem JS; Vanes LA
    Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.